Perospirone hydrochloride tablets for depressive disorder

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 25 Nov 2020: Trial started, NCT04826510
  2. 1 Apr 2021: Trial registered, NCT04826510

The trials

NCT04826510: Efficacy and Safety of Peropirone Hydrochloride Tablets in the Treatment of Adolescent Bipolar Disorder Depression

State
State not given
Phase
Phase 4
People
189 planned
Started
25 Nov 2020
Primary completion
30 Jun 2021
Arms
Perospirone hydrochloride group
Results
None posted
  1. 25 Nov 2020: Trial started
  2. 1 Apr 2021: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.